Survival of MM red cells during hypothermia in two patients with anti-M.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6829057)

Published in Transfusion on April 07, 1983

Authors

S R Kurtz, R Ouellet, A McMican, C R Valeri

Articles by these authors

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72

The platelet function defect of cardiopulmonary bypass. Blood (1993) 2.63

Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation (2001) 2.54

Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol (1982) 1.96

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol (1998) 1.95

Does erythrocyte infusion improve 3.2-km run performance at high altitude? Eur J Appl Physiol Occup Physiol (1998) 1.94

In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90

Electrical alternans and cardiac electrical instability. Circulation (1988) 1.86

Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci U S A (1972) 1.84

Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol (1989) 1.77

Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost (1994) 1.66

Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg (1991) 1.57

Hypothermia-induced reversible platelet dysfunction. Ann Surg (1987) 1.51

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg (1995) 1.51

Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Ann Thorac Surg (1994) 1.45

Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg (1996) 1.39

Platelet size as a determinant of platelet function. J Lab Clin Med (1983) 1.37

Candida lusitaniae: a new opportunistic pathogen of the urinary tract. Diagn Microbiol Infect Dis (1984) 1.34

Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg (1993) 1.34

Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med (1969) 1.34

Arachidonic acid metabolism by platelets of differing size. Br J Haematol (1983) 1.29

Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest (1996) 1.29

Use of a high-sensitivity rapid strep test without culture confirmation of negative results: 2 years' experience. J Fam Pract (2000) 1.26

Infrared fibers for radiometer thermometry in hypothermia and hyperthermia treatment. IEEE Trans Biomed Eng (1989) 1.22

Platelet size and age determine platelet function independently. Blood (1984) 1.22

The relation between response to hypotonic stress and the 51Cr recovery in vivo of preserved platelets. Transfusion (1974) 1.21

Platelet size does not correlate with platelet age. Blood (1983) 1.19

Pulmonary edema after aneurysm surgery is modified by mannitol. Ann Surg (1989) 1.19

Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion (1999) 1.18

Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells. J Bone Joint Surg Am (1991) 1.16

The role of anticoagulation in the measurement of platelet volumes. Am J Clin Pathol (1983) 1.15

Myocardial depression during sepsis. Am J Surg (1977) 1.13

Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res (1994) 1.13

Red-cell 2,3-diphosphoglycerate and creatine levels in patients with red-cell mass deficits or with cardiopulmonary insufficiency. N Engl J Med (1969) 1.13

Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann Surg (1992) 1.13

The role of ABO matching in platelet transfusion. Eur J Haematol (1993) 1.10

Pulmonary leukosequestration induced by hind limb ischemia. Ann Surg (1987) 1.09

Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol (1985) (1991) 1.09

Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci U S A (2001) 1.08

Prostacyclin and thromboxane A2 moderate postischemic renal failure. Surgery (1985) 1.08

Improving trend in hypertension control in a black inner city community. Am J Epidemiol (1978) 1.06

Massive transfusion in patients with severe traumatic injuries. Vox Sang (2009) 1.06

A critical survey of fresh-frozen plasma use. Transfusion (1986) 1.05

The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution. Ann Surg (1988) 1.05

Treatment of pulmonary embolism with prostacyclin. Surgery (1980) 1.04

In vitro studies of cryopreserved baboon granulocytes. Transfusion (1979) 1.02

Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg (1988) 1.02

Physiologic effects of 2,3-DPG-depleted red cells with high affinity for oxygen. J Appl Physiol (1971) 1.02

Accuracy and reproducibility of the AutoMicrobic System Gram-Negative General Susceptibility-Plus Card for testing selected challenge organisms. J Clin Microbiol (1985) 1.01

Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation (1987) 1.00

Reinfusion of shed blood after orthopaedic procedures in children and adolescents. J Bone Joint Surg Am (1993) 0.99

Adverse effects of transfusion therapy during abdominal aortic aneurysectomy. Surgery (1978) 0.99

Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood (1991) 0.98

Hemostatic effectiveness of platelets stored at 22 degrees C. N Engl J Med (1971) 0.97

Thromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia. Circ Res (1989) 0.97

Pulmonary hypertension and leukosequestration after lower torso ischemia. Ann Surg (1987) 0.97

Surface area and volume changes during maturation of reticulocytes in the circulation of the baboon. J Lab Clin Med (1997) 0.97

Thromboxane A2 moderates permeability after limb ischemia. Ann Surg (1985) 0.97

Thromboxane mediates the ischemia-induced neutrophil oxidative burst. Surgery (1989) 0.97

Lavage with leukotriene B4 induces lung generation of tumor necrosis factor-alpha that in turn mediates neutrophil diapedesis. Surgery (1993) 0.97

Neutrophil elastase and oxygen radicals: synergism in lung injury after hindlimb ischemia. Am J Physiol (1991) 0.96

Neutrophil accumulations due to pulmonary thromboxane synthesis mediate acid aspiration injury. J Appl Physiol (1985) (1991) 0.96

Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Am J Physiol (1989) 0.96

Ischemia of the limb stimulates thromboxane production and myocardial depression. Surg Gynecol Obstet (1983) 0.96

Automated differential agglutination technic to measure red cell survival. I. Methodology. Transfusion (1968) 0.95

Measuring percent oxygen saturation of hemoglobin, percent carboxyhemoglobin and methemoglobin, and concentrations of total hemoglobin and oxygen in blood of man, dog, and baboon. Clin Chem (1980) 0.95

Hemostatic effectiveness of liquid-preserved and previously frozen human platelets. N Engl J Med (1974) 0.95

A Mac-1 antibody reduces liver and lung injury but not neutrophil sequestration after intestinal ischemia-reperfusion. Surgery (1992) 0.94

Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol (1986) 0.94

Cryogenic preservation of monocytes from human blood and plateletpheresis cellular residues. Blood (1981) 0.94

Arachidonic acid metabolites mediate early burn edema. J Trauma (1984) 0.94

Studies of human platelets by 19F and 31P NMR. FEBS Lett (1979) 0.93

Synthesis and photodynamic activities of silicon 2,3-naphthalocyanine derivatives. J Med Chem (1994) 0.92

Circulation and hemostatic effectiveness of platelets stored at 4 C or 22 C: studies in aspirin-treated normal volunteers. Transfusion (1976) 0.92

Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents. Surgery (1992) 0.92

Reactive oxygen species and elastase mediate lung permeability after acid aspiration. J Appl Physiol (1985) (1992) 0.92

Inhibition of thromboxane (Tx) synthesis by free radical scavengers. J Trauma (1988) 0.92

Effect of erythrocyte storage and oxyhemoglobin affinity changes on cardiac function. Am J Physiol (1985) 0.92

Erythrocyte, plasma, and blood volume of healthy young men. Med Sci Sports Exerc (1992) 0.91

Neutrophil adherence receptors (CD 18) in ischemia. Dissociation between quantitative cell surface expression and diapedesis mediated by leukotriene B4. J Immunol (1990) 0.91

Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med (1985) 0.91

Synergism between leukotriene B4 and thromboxane A2 in mediating acid-aspiration injury. Surgery (1992) 0.91

Liquid and freeze preservation of baboon platelets. Cryobiology (1981) 0.90

Clinical evaluation of concentrated red cells. N Engl J Med (1969) 0.90

Modification of inflammatory response to aspiration with ibuprofen. Am J Physiol (1982) 0.90

Leukotrienes but not complement mediate limb ischemia-induced lung injury. Ann Surg (1989) 0.90

Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease. Pediatr Res (1979) 0.90

Glycerol hyperhydration: hormonal, renal, and vascular fluid responses. J Appl Physiol (1985) (1995) 0.89

The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response. Photochem Photobiol (1993) 0.89

Receptor-mediated targeting of phthalocyanines to macrophages via covalent coupling to native or maleylated bovine serum albumin. Photochem Photobiol (1999) 0.89

Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice. Br J Cancer (1999) 0.89

"Acquired immunodeficiency" of blood stored overnight. N Engl J Med (1983) 0.89

Improved viability of previously frozen platelets. Blood (1972) 0.89

Binding interactions and conformational changes induced by sulfonated aluminum phthalocyanines in human serum albumin. Arch Biochem Biophys (1999) 0.89

Tumor necrosis factor-alpha mediates acid aspiration-induced systemic organ injury. Ann Surg (1990) 0.88

Viability and function of preserved red cells. N Engl J Med (1971) 0.88

Autologous platelet-rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the preparation of platelet gel. Vox Sang (2001) 0.88

Subtle alternating electrocardiographic morphology as an indicator of decreased cardiac electrical stability. Comput Cardiol (1985) 0.88